Latest: Watch here for details of new products and services.
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Comparison
- Forums
- Visit our forums
- Jobs
- Visit our job site
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire New!
- Contact us
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Kalight is devoted to developing patents dealing with viral CNS conditions and seeking licensees and partnerships. Currently, it is marketing its patent for certain herpes neurological conditions. More
Dar Al Dawa is a generic manufacturing company in the Middle East. More
BioVex : Developing a new class of vaccines to treat and prevent cancer - OncoVEX and ImmunoVEX, and a functional genomics platform for gene determination in the nervous system - NeuroVEX More
Development & Marketing of Pharmaceuticals More
Using its unique technology, biopharmaceutical company, Aptagen develops targeted drugs and licenses out new drugs to global pharmaceutical companies. More
Debio finances and manages drug development for serious medical conditions More
A DNA engineering company and inventors of Red/ET Recombination, a breakthrough DNA engineering platform. We engage in further innovative R&D and provide licenses and customized service. More
Morphochem discovers and develops highly selective small molecule compounds for the medicines of tomorrow More
Quality Translations for Science, Industry, Government since 1957 More
Your selection
Browse By
- Therapeutic target
- Auditory
- Opthalmic
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us